Aviance Capital Partners’s Colgate-Palmolive CL Stock Holding History

Aviance Capital Partners’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$245K	Hold	2,880	–	–	0.03%	336
2025 Q4	$228K	Hold	2,880	–	–	0.03%	342
2025 Q3	$230K	Sell	2,880 -200	-6%	-$17.1K	0.03%	335
2025 Q2	$280K	Buy	3,080 +60	+2%	+$5.48K	0.04%	295
2025 Q1	$283K	Sell	3,020 -100	-3%	-$8.95K	0.04%	286
2024 Q4	$284K	Sell	3,120 -300	-9%	-$28.6K	0.04%	271
2024 Q3	$355K	Sell	3,420 -15	-0.4%	-$1.53K	0.05%	258
2024 Q2	$333K	Sell	3,435 -215	-6%	-$19.8K	0.05%	246
2024 Q1	$329K	Buy	3,650 +1,100	+43%	+$93.2K	0.05%	249
2023 Q4	$203K	Buy	+2,550	New	+$192K	0.04%	240
2023 Q1	–	Sell	-2,569	Closed	-$202K	–	264
2022 Q4	$202K	Buy	+2,569	New	+$193K	0.05%	266
2022 Q3	–	Sell	-2,530	Closed	-$203K	–	259
2022 Q2	$203K	Buy	+2,530	New	+$198K	0.05%	252
2022 Q1	–	Sell	-2,530	Closed	-$216K	–	253
2021 Q4	$216K	Buy	+2,530	New	+$198K	0.04%	244
2021 Q3	–	Sell	-2,530	Closed	-$206K	–	255
2021 Q2	$206K	Buy	+2,530	New	+$207K	0.04%	245
2021 Q1	–	Sell	-2,550	Closed	-$218K	–	265
2020 Q4	$218K	Buy	+2,550	New	+$211K	0.04%	245
2019 Q4	–	Sell	-2,800	Closed	-$206K	–	231
2019 Q3	$206K	Hold	2,800	–	–	0.06%	207
2019 Q2	$201K	Buy	+2,800	New	+$199K	0.06%	207
2018 Q2	–	Sell	-2,800	Closed	-$200K	–	226
2018 Q1	$200K	Sell	2,800 -475	-15%	-$34.2K	0.06%	214
2017 Q4	$247K	Hold	3,275	–	–	0.08%	199
2017 Q3	$239K	Sell	3,275 -6,100	-65%	-$440K	0.08%	191
2017 Q2	$695K	Buy	9,375 +275	+3%	+$20.4K	0.22%	126
2017 Q1	$666K	Hold	9,100	–	–	0.24%	124
2016 Q4	$596K	Hold	9,100	–	–	0.21%	123
2016 Q3	$675K	Hold	9,100	–	–	0.24%	110
2016 Q2	$666K	Sell	9,100 -49	-0.5%	-$3.49K	0.25%	108
2016 Q1	$646K	Buy	9,149 +49	+0.5%	+$3.26K	0.22%	110
2015 Q4	$606K	Sell	9,100 -300	-3%	-$20K	0.21%	121
2015 Q3	$597K	Sell	9,400 -138	-1%	-$9.02K	0.25%	113
2015 Q2	$624K	Sell	9,538 -150	-2%	-$10.2K	0.23%	126
2015 Q1	$672K	Hold	9,688	–	–	0.25%	126
2014 Q4	$670K	Hold	9,688	–	–	0.25%	125
2014 Q3	$632K	Buy	9,688 +638	+7%	+$42.1K	0.24%	139
2014 Q2	$617K	Sell	9,050 -308	-3%	-$20.6K	0.24%	132
2014 Q1	$607K	Hold	9,358	–	–	0.26%	119
2013 Q4	$610K	Buy	9,358 +758	+9%	+$48.5K	0.26%	116
2013 Q3	$510K	Buy	8,600 +1,200	+16%	+$71.1K	0.24%	128
2013 Q2	$424K	Buy	+7,400	New	+$439K	0.23%	124

Other funds holding CL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Aviance Capital Partners's CL Position: Q1 2026 in Review

Aviance Capital Partners held its Colgate-Palmolive (CL) position steady in Q1 2026 at 2,880 shares worth $245K. The position accounts for 0.03% of the portfolio, ranked #336.

Aviance Capital Partners first reported a position in CL in Q2 2013 and has held it in 37 quarters since. The position peaked at $695K in Q2 2017. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

Aviance Capital Partners held 2,880 shares of Colgate-Palmolive worth $245K as of Q1 2026.
Aviance Capital Partners left its Colgate-Palmolive share count unchanged in Q1 2026.
Colgate-Palmolive made up 0.03% of Aviance Capital Partners's portfolio in Q1 2026, its #336 holding.
Aviance Capital Partners first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 37 quarters since.
Aviance Capital Partners's Colgate-Palmolive position peaked at $695K in Q2 2017.
1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Aviance Capital Partners's 13F filing for Q1 2026, filed 6 May 2026.